Back to Journals » Patient Related Outcome Measures » Volume 2

Modified Severity of Dyspepsia Assessment pain scale: a new tool for measuring upper abdominal pain in osteoarthritis patients taking NSAIDs

Authors Welle J, Fort J, Crawley J, Cryer B, Dickerhoof R, Turner M, Miller K

Published 23 June 2011 Volume 2011:2 Pages 135—143

DOI https://doi.org/10.2147/PROM.S18077

Review by Single-blind

Peer reviewer comments 3


Jennifer Welle1, John Fort2, Joseph Crawley3, Byron Cryer4, Rene Dickerhoof1, Michelle P Turner1, Kimberly L Miller1
1
ICON Clinical Research, The Embarcadero, San Francisco, CA, USA; 2POZEN Inc, Raleigh Road, Chapel Hill, NC, USA; 3AstraZeneca LP, Concord Pike, Wilmington, DE, USA; 4UT Southwestern Medical Center, Harry Hines Boulevard, Dallas, TX, USA

Background: This study evaluated the electronically administered modified Severity of Dyspepsia Assessment (mSODA) pain scale, a six-item measure of upper abdominal pain intensity, for daily use in osteoarthritis patients taking nonsteroidal anti-inflammatory drugs.
Methods: Once the mSODA pain scale was isolated, cognitive debriefing interviews (n = 30) were used to examine its appropriateness in the target population. Following administration of the instrument in two Phase III pivotal trials, the data were analyzed to examine reliability, validity, responsiveness, and the minimal important difference.
Results: Using a subset of trial data (n = 90 patients), the mSODA pain scale proved to be a unidimensional, highly internally consistent instrument (α = 0.93) with good test-retest reliability (intraclass correlation coefficient 0.77). Construct validity was established via moderate correlations with other similar patient-reported outcomes. Additionally, known-groups validity demonstrated that the mSODA pain scale could distinguish between subjects who did and did not report gastrointestinal symptoms and antacid use (both P values ≤ 0.05). The mSODA pain scale was also responsive to change in heartburn at weeks 6 and 12 (Guyatt's statistic = 1.7 and 2.6, respectively), and the minimal important difference obtained via ½ SD was 5.7 (range 2–47).
Conclusion: This research suggests that the mSODA pain scale is both feasible and valid for assessing dyspepsia in patients taking nonsteroidal anti-inflammatory drugs for relief of symptoms of osteoarthritis.

Keywords: mSODA pain scale, questionnaire, antacid, patients, heartburn

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]